Akebia Therapeutics, Inc.AKBA

Market cap

$438.6M

P/E ratio

	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	33	50	187	70	107	150	231	152	93	45	54
Marketable securities, current	76	89	73	495	217	0	40	-	-	-	-
Total cash & short-term investments	109	138	260	565	324	150	271	152	93	45	54
Accounts receivable, net	0	-	-	34	17	39	27	51	39	39	34
Inventories	-	-	-	-	114	116	61	38	22	16	16
Total current assets	110	141	296	358	468	310	371	272	185	118	114
Property, plant and equipment, net	209,928	1	3	4	8	10	9	7	5	4	2
Total non-current assets	1	2	4	6	528	462	273	254	167	124	107
Total assets	111	143	300	364	997	771	644	526	352	242	221
Accounts payable	2	2	2	7	43	39	41	34	18	15	15
Long-term debt, current	-	-	-	-	-	-	-	98	32	18	-
Total current liabilities	7	12	114	144	266	208	187	256	125	100	81
Long-term debt, non-current	-	-	-	-	-	76	96	-	34	17	39
Total non-current liabilities	0	0	118	101	95	168	209	193	218	172	189
Total liabilities	7	12	232	245	361	376	397	449	342	272	270
Common stock and paid-in capital	-	-	-	-	0	0	0	0	0	0	0
Retained earnings	-101	-161	-297	-374	-514	-794	-1,178	-1,460	-1,553	-1,609	-1,678
Stockholders' equity	104	131	68	119	636	395	248	76	9	-31	-49
Total debt	-	-	-	-	-	76	96	98	66	35	39
Net debt	-	-	-	-	-	-74	-175	-54	-27	-10	-15
D/E ratio (%)	-	-	-	-	-	19.2	38.9	127.6	707.3	-113.4	-78.7
Working capital	-	-	-	-